Table 3.
Patent Literature on nutraceuticals.
| Patent Number | Patent Title | Year | Reference |
| CN104193540B | Fertilizer and insecticide use nutraceuticals disease prevention, disease prevention nutraceutical insecticidal fertilizer slow-release agent and the use thereof | 2016 | [200] |
| CN104262041A | Nutritional disease-preventing pesticide fertilizer and application thereof, nutritional disease-preventing pesticide fertilizer slow release agent and application thereof | 2015 | [201] |
| CN101371628A | Disease-preventing nutrient bag and manufacture method thereof | 2009 | [202] |
| US9669199B2 | Bio-synchronous transdermal drug delivery for longevity, anti-ageing, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals and the treatment of hyperglycemia, Alzheimer’s disease, sleep disorders, Parkinson’s disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like | 2017 | [203] |
| WO2008054788A3 | Transdermal delivery techniques for drugs, nutraceuticals and other active substances | 2008 | [204] |
| EP1835818B1 | Product and method for producing a vehicle for oral administration of nutraceuticals | 2011 | [205] |
| US5955269A | Methods of screening foods for nutraceuticals | 1999 | [206] |
| EP2349302A4 | Cardio-protective effects of nutraceuticals isolated from nigella sativa seeds | 2012 | [207] |
| US10517316B2 | Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for bovine health | 2016 | [208] |
| US20080118583A1 | Phyto-nutraceutical synergistic composition for Parkinson’s disease | 2008 | [209] |
| AU2005200614A1 | Nutraceuticals for the treatment, protection and restoration of connective tissues | 2005 | [210] |
| US7494674B2 | Nutraceutical with tart cherries and method of treatment therewith | 2009 | [211] |
| CN101534807A | Pharmaceutical and nutraceutical products comprising vitamin k2 | 2009 | [212] |
| US20100063153A1 | Anti-cholesterolemic compounds and methods of use | 2010 | [213] |
| US6630160B1 | Process to modulate disease risk with doses of a nutraceuticals | 2003 | [214] |
| US6080788A | Composition for improvement of cellular nutrition and mitochondrial energetics | 2000 | [215] |
| US20160089411A1 | Method and composition for treating symptoms of sickle cell disease | 2016 | [216] |
| CN102088995B | The use of angiogenin and angiogenin agonist for treating diseases and disorders | 2016 | [217] |
| US20080193590A1 | Highly refined cellulose nutraceutical compositions and methods of use | 2008 | [218] |
| US20040009244A1 | Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity | 2004 | [219] |
| US20110009360A1 | Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis | 2011 | [220] |
| CN1822768A | Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver | 2006 | [221] |
| US20210292265A1 | Chalcones and derivatives for use in medicaments and nutraceuticals | 2021 | [222] |
| US20210113554A1 | Nutraceuticals Having Sustained Release for Improved Bioavailability and Method of Production | 2021 | [223] |
| US20210290722A1 | Nutraceuticals supplement composition for regulating metabolism and anti-aging | 2021 | [224] |
| US10981083B2 | Process for fractionation and extraction of herbal plant material to isolate extractives for pharmaceuticals and nutraceuticals | 2021 | [225] |
| US20220040248A1 | Prevention of Neuroinflammation associated Memory Loss Using Nutraceutical Compositions | 2022 | [226] |
| US11270791B2 | In silico methods for obtaining nutraceutical compositions | 2022 | [227] |
| US20220160744A1 | Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and b vitamins, preparation and uses thereof | 2022 | [228] |
| US20220184100A1 | Enhanced d vitamin nutraceutical compositions and methods for making and used same | 2022 | [229] |